Soligenix SNGX
NASDAQ SNGX
$0.37 +0.01 (+2.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Soligenix (SNGX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Soligenix (SNGX) posted Return on Capital Employed [ROCE] of -219.07% for Q2 2026, up 144.79 percentage points from -363.86% a year earlier and up 43.36 percentage points from the prior quarter.

Analysis

Soligenix (SNGX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Soligenix's Return on Capital Employed [ROCE] came in at -219.29%, down 11.07 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +20.45 percentage points (FY2020 to FY2025).
  • In prior years, Soligenix's Return on Capital Employed [ROCE] was -208.22% in FY2024 (-77.44 pp), -130.77% in FY2023 (+220.11 pp), -350.89% in FY2022 (-274.24 pp) and -76.65% in FY2021 (+163.09 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -928.19% in Q1 2023 to a high of -56.59% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last six quarters, with an average year-over-year change of -5.52 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 481.80 percentage points; the weakest was Q1 2023, with a drop of 844.76 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -262.43% (Q1 2026), -180.42% (Q4 2025) and -236.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Soligenix 5.90 Mn 5.90 Mn - -219.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -219.07%
Mar 31, 2026 -262.43%
Dec 31, 2025 -180.42%
Sep 30, 2025 -236.68%
Jun 30, 2025 -363.86%
Dec 31, 2024 -193.70%
Sep 30, 2024 -139.43%
Jun 30, 2024 -298.36%
Mar 31, 2024 -446.39%
Dec 31, 2023 -175.03%
Sep 30, 2023 -129.63%
Jun 30, 2023 -155.56%
Mar 31, 2023 -928.19%
Sep 30, 2022 -152.36%
Jun 30, 2022 -113.27%
Mar 31, 2022 -83.43%
Dec 31, 2021 -59.53%
Sep 30, 2021 -56.59%
Jun 30, 2021 -47.33%
Mar 31, 2021 -57.64%
API Access

Soligenix Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNGX&period=max&api_key=YOUR_API_KEY